Case Report
Reduction in tumor grade and Ki-67 in postmenopausal patient with node-positive invasive ductal carcinoma following combination hormone replacement therapy cessation: a case report
Translational Breast Cancer Research
2022;
3:
29
(30 July 2022)
Case Report
Metastatic breast cancer in a transgender female with history of mantle field radiation and free silicone breast injections: case report
Translational Breast Cancer Research
2022;
3:
28
(30 July 2022)
Case Report
A case report of gender-affirming mastectomy in a transgender individual with breast cancer
Translational Breast Cancer Research
2022;
3:
27
(30 July 2022)
Review Article
Thoughts on therapy strategy in the era of “after anti-HER2 TKI” in CSCO BC Guidelines 2022
Translational Breast Cancer Research
2022;
3:
26
(30 July 2022)
Review Article
Key points of breast cancer management under public health emergencies
Translational Breast Cancer Research
2022;
3:
25
(30 July 2022)
Original Article
A new pathological assessment method to assess residual lesions after neoadjuvant chemotherapy for breast cancer, residual disease in breast and nodes combined with Ki-67 (RDBN-K)
Translational Breast Cancer Research
2022;
3:
24
(30 July 2022)
Original Article
Five-year survival in luminal breast cancer patients: relation with intratumoral activity of proteasomes
Translational Breast Cancer Research
2022;
3:
23
(30 July 2022)
Consensus
CSCO expert consensus on the diagnosis and treatment of breast cancer brain metastasis
Translational Breast Cancer Research
2022;
3:
22
(30 July 2022)
Editorial
Comments to the Chinese Society of Clinical Oncology (CSCO) Breast Cancer Guidelines 2022
Translational Breast Cancer Research
2022;
3:
21
(30 July 2022)
